Journal ArticleDOI
Informing patients about drug side effects
Louis A. Morris,David E. Kanouse +1 more
TLDR
Results support the notion of an “attribution-labeling” process rather than a “suggestion” effect, and those who recieved the PPI were more likely to attribute experienced reactions to the drug.Abstract:
Two hundred forty-nine newly diagnosed hypertensive patients prescribed thiazide medication were recruited for study. Two-thirds were given a leaflet or patient package insert (PPI) that described the drug and its possible side effects, and one-third were not. At a revisit about 1 month later, patients were asked whether they had experienced any of 17 different “health problems.” For each problem that they experienced, they were asked whether they thought the problem was related to the medicine they were taking. Ten of the health problems were taken verbatim from the PPI's list of possible drug side effects. Patients who received the PPI reported experiencing about the same number of side effects as the non-PPI subjects. However, those who recieved the PPI were more likely to attribute experienced reactions to the drug. This was true both for reactions specifically listed in the PPI and for similar reactions not listed. Results support the notion of an “attribution-labeling” process rather than a “suggestion” effect.read more
Citations
More filters
Journal ArticleDOI
Informed decision making in outpatient practice: time to get back to basics.
TL;DR: Informed decision making among this group of primary care physicians and surgeons was often incomplete, and this deficit was present even when criteria for informed decision making were tailored to expect less extensive discussion for decisions of lower complexity.
Journal ArticleDOI
How Doctors and Patients Discuss Routine Clinical Decisions: Informed Decision Making in the Outpatient Setting
TL;DR: The informed consent process in routine, primary care office practice did not fulfill the criteria considered integral to informed decision making, and Physicians frequently described the nature of the decision, less frequently discussed risks and benefits, and rarely assessed the patient's understanding of the decisions.
Journal ArticleDOI
Intended and Unintended Consequences of Warning Messages: A Review and Synthesis of Empirical Research:
TL;DR: In this article, the authors review the diverse literature on the effects of product warnings and conclude that warnings inform rather than persuade consumers and consumers selectively attend to warning messages, and that consumers selectively ignore warning messages.
Journal ArticleDOI
What do patients want to know about their medicines, and what do doctors want to tell them?: A comparative study
TL;DR: The results showed that people ‘preferred’ the explanations based on what the participants in the earlier study wanted to know about drug prescriptions, rather than whether or not the explanations conveyed negative information.
Journal ArticleDOI
Prescription information leaflets: a national survey.
S. Gibbs,W. E. Waters,CF George +2 more
TL;DR: Patients who received leaflets knew more about their medicines, especially the side effects and were significantly more satisfied than the patients who were not given additional written information.
References
More filters
Journal ArticleDOI
Adverse nondrug reactions.
TL;DR: Healthy university students and hospital staff taking no medications were surveyed by questionnaire to obtain data on the occurrence of many symptoms often listed as side effects of drugs.
Journal ArticleDOI
Judgments of trained observers on adverse drug reactions.
TL;DR: Patients admitted to a department of medicine during five consecutive months were followed by an investigator who identified 110 clinical manifestations which could have been considered adverse drug reactions, but only 27 reactions of these were attributed to the same drug by all three observers.
Journal ArticleDOI
Pre-existing conditions, placebo reactions, and "side effects".
TL;DR: The purpose of these studies was to explore the possible relationship between pretreatment conditions and placebo reactions and the subsequent appearance of symptoms that could be regarded as placebo reactions.